健康元：健康元药业集团股份有限公司2023年社会责任报告（英文版）.PDF

1、健康元药业集团股份有限公司二二三年社会责任报告2023Social Responsibility ReportFor the health For the futureSafeguarding Product Quality05Quality Management System Quality Risk Control Quality Training for Employees Intellectual Property Rights Protection Protection of Customer Rights and InterestsSupply Chain Management32

2、3840434548The Report at a GlanceAbout JoincareResponsible GovernanceChairmans Statement01030402Group OverviewOrganisational Structure Corporate Culture Key Performance Honours 810111112CSR Strategy CSR Governance Communication on CSR Compliance Governance Risk ManagementCarrying Forward the Party-Ma

3、sses Spirit Integrity and Business Ethics Information Security1515162225262830ContentsAccess to Healthcare06Focusing on R&D and Innovation Paying Attention to Rare Diseases Treatment Improving Product Availability ImprovingProductAffordabilityImproving Healthcare5763656871Operating with Green Sustai

4、nabilityTalent ManagementData List of Key Performance IndicatorsPublic Welfare and Charity08071009Environmental Management System Addressing Climate ChangeEnergy ManagementEmission Management Resource Utilisation ManagementBiodiversity Conservation100104110111116118 Protection of Rights and Interest

5、s of Employees Improving Talent ManagementOccupational Health and Safety778292Promoting Industry-based Welfare Promoting Health-based Welfare and CharityInvolvement in Public Welfare1201201264Joincare Pharmaceutical Group Industry Co.,Ltd.OverviewThe report,covering the period from 1 January 2023 to

6、 31 December 2023,is the seventh corporate social responsibility(CSR)report issued by Joincare Pharmaceutical Group Industry Co.,Ltd.(Stock Code:600380).In view of the continuity and comparability of certain data,some contents of this report may be extended or traced back to other periods where appl